Thermo Fisher Scientific Inc
NYSE:TMO

Watchlist Manager
Thermo Fisher Scientific Inc Logo
Thermo Fisher Scientific Inc
NYSE:TMO
Watchlist
Price: 424.24 USD -0.57% Market Closed
Market Cap: 160.1B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+41%
Revenue
Forecast
+12%
Operating Income
Forecast
N/A
Net Income
Forecast
+24%

Wall Street
Price Targets

TMO Price Targets Summary
Thermo Fisher Scientific Inc

Wall Street analysts forecast TMO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TMO is 639.15 USD with a low forecast of 479.75 USD and a high forecast of 805.35 USD.

TMO Lowest Forecast
Wall Street Target
479.75 USD
13% Upside
TMO Average Forecast
Wall Street Target
639.15 USD
51% Upside
TMO Highest Forecast
Wall Street Target
805.35 USD
90% Upside
Lowest
Price Target
479.75 USD
13% Upside
Average
Price Target
639.15 USD
51% Upside
Highest
Price Target
805.35 USD
90% Upside
Thermo Fisher Scientific Inc Competitors:
Price Targets
G
688046
GemPharmatech Co Ltd
76% Upside
688222
HitGen Inc
12% Upside
AZTA
Azenta Inc
88% Upside
MCAP
MedCap AB (publ)
34% Upside
G
688046
GemPharmatech Co Ltd
76% Upside
688222
HitGen Inc
12% Upside
AZTA
Azenta Inc
88% Upside
MCAP
MedCap AB (publ)
34% Upside
CSBR
Champions Oncology Inc
55% Upside
TECH
Bio-Techne Corp
65% Upside
BIOT
Biotage AB
22% Upside
CGEN
Compugen Ltd
227% Upside

Revenue
Forecast

Revenue Estimate
Thermo Fisher Scientific Inc

For the last 8 years the compound annual growth rate for Thermo Fisher Scientific Inc's revenue is 11%. The projected CAGR for the next 3 years is 6%.

11%
Past Growth
6%
Estimated Growth
Estimates Accuracy
0%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Thermo Fisher Scientific Inc

For the last 8 years the compound annual growth rate for Thermo Fisher Scientific Inc's operating income is 14%. The projected CAGR for the next 3 years is 24%.

14%
Past Growth
24%
Estimated Growth
Estimates Accuracy
-25%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Thermo Fisher Scientific Inc

For the last 8 years the compound annual growth rate for Thermo Fisher Scientific Inc's net income is 15%. The projected CAGR for the next 3 years is 20%.

15%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-23%
Average Miss
What are analyst estimates?

See Also

Summary
TMO intrinsic value, competitors valuation, and company profile.
DCF Valuation
TMO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TMO stock valuation using valuation multiples.
Wall Street Estimates
TMO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TMO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TMO's stock price target?
Price Target
639.15 USD

According to Wall Street analysts, the average 1-year price target for TMO is 639.15 USD with a low forecast of 479.75 USD and a high forecast of 805.35 USD.

What is Thermo Fisher Scientific Inc's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Thermo Fisher Scientific Inc's revenue is 11%. The projected CAGR for the next 3 years is 6%.

What is Thermo Fisher Scientific Inc's Operating Income forecast?
Projected CAGR
24%

For the last 8 years the compound annual growth rate for Thermo Fisher Scientific Inc's operating income is 14%. The projected CAGR for the next 3 years is 24%.

What is Thermo Fisher Scientific Inc's Net Income forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for Thermo Fisher Scientific Inc's net income is 15%. The projected CAGR for the next 3 years is 20%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 249,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.